CompoAtlas

MediHerb Broncafect

Natural health product licensed in Canada

Licence holder
Integria Healthcare (Australia) Pty Ltd
NPN or DIN-HM
80125480
Status
Active licence
Licence date
11 July 2023
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Asclepias tuberosa

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 375 mg

93.75 mgNot calculated
Echinacea purpurea

Source : Echinacea purpurea - Racine

Extract : Matériel brut sec

Extraction ratio : 6:1

Dry plant equivalent : 375 mg

62.5 mgNot calculated
Glycyrrhiza glabra

Source : Glycyrrhiza glabra - racine

Extract : Matériel brut sec

Extraction ratio : 12:1

Dry plant equivalent : 750 mg

62.5 mgNot calculated
Marrubium vulgare

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 180 mg

45 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Phosphate de dicalcium dihydraté, Cellulose microcristalline, Stéarate de magnésium, Hypromellose, Glycolate d'amidon sodique, Extrait de racine de Gingembre, Huile de thym

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Compriméminimum: 2 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Glycyrrhiza glabra is traditionally used in Herbal Medicine as an expectorant to help relieve chest complaints, such as mucous buildup catarrhs, coughs and bronchitis. Used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract. Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections. Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Echinacea purpurea is traditionally used in Herbal Medicine to help relieve cold symptoms. Echinacea purpurea is traditionally used in Herbal Medicine to help relieve symptoms of colds and upper respiratory tract infections. Echinacea purpurea is traditionally used in Herbal Medicine to help relieve symptoms of upper respiratory tract infections.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80125480

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line